Neuland Laboratories Ltd
NEULANDLAB
Company Profile
Business description
Neuland Laboratories Ltd is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets. The group has only one reportable segment manufacture of active pharmaceutical ingredients and allied services. It has presence in India, Europe, USA and North America, and Rest of the world.
Contact
Road Number 82, Jubilee Hills
Plot No. 573A-III, Phoenix IVY Building, 11th Floor-5th Office Level
HyderabadTG500033
INDT: +91 4067611600
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
3,881
Stocks News & Analysis
stocks
ASX major bank drives strong quarterly profit
Profit momentum remains robust yet shares overvalued.
stocks
Ask the analyst: What to expect in earnings season?
The key metrics that matter this earnings season.
stocks
ASX healthcare share remains undervalued ahead of earnings
Margin recovery remains the key driver for this ASX healthcare share.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,040.50 | 12.90 | 0.14% |
| CAC 40 | 8,372.28 | 0.00 | 0.00% |
| DAX 40 | 25,099.00 | 335.88 | 1.36% |
| Dow JONES (US) | 51,947.25 | 235.60 | 0.46% |
| FTSE 100 | 10,736.23 | 97.06 | 0.91% |
| HKSE | 25,143.55 | 180.32 | 0.72% |
| NASDAQ | 24,975.82 | 161.87 | -0.64% |
| Nikkei 225 | 64,764.01 | 152.86 | 0.24% |
| NZX 50 Index | 13,807.31 | 35.02 | 0.25% |
| S&P 500 | 7,411.98 | 3.68 | 0.05% |
| S&P/ASX 200 | 8,870.50 | 12.60 | 0.14% |
| SSE Composite Index | 3,826.70 | 12.50 | 0.33% |